Accessibility Menu
Axm Pharma logo

Axm Pharma(OTC) AXMP

Market Cap$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-100%
1 Year-99%
1 Month-90%
$0.00
+0.00%
+0.00Today
Axm Pharma last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-31
Axm Pharma stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99%USD 0.002026-07-13
1 month-90%USD 0.002026-06-30
3 month-99%USD 0.002026-04-13
Year to date-99%USD 0.002025-12-03
1 year-99%USD 0.002025-06-18
3 year+0%USD 0.002023-06-08
5 year-99.5%USD 0.002021-07-30
Since inception-99.99%USD 0.022018-10-15

Axm Pharma Financials at a Glance

Market Cap

$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-34.42 (Low)

Price

$0.00

Volume

300

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 25, 2024

AXMP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Axm Pharma

AXM Pharma, Inc. is a healthcare company focused on producing and distributing both over-the-counter and prescription medications in the People's Republic of China. Headquartered in New York, the company aims to meet the growing demand for pharmaceutical products in a rapidly expanding market.

Products and Services
  • Over-the-counter medications for common ailments
  • Prescription medications targeting specific health conditions
  • Distribution services within the Chinese pharmaceutical market
Growth Outlook
  • China's pharmaceutical market is projected to grow significantly
  • Increasing demand for healthcare products supports revenue potential
  • Strategic positioning in a high-growth industry enhances market opportunities
Financial Highlights
  • Market capitalization stands at approximately $40,860
  • Recent stock price shows a range from $0.000001 to $0.0001
  • Volume averages around 211,259 shares traded
AXM Pharma, Inc. operates in a dynamic sector with substantial growth potential. The company's focus on the Chinese market aligns with the increasing demand for healthcare products, which is expected to drive revenue growth. The current market capitalization reflects the company's position within the industry, while the stock price range indicates a low entry point for potential investors. With a strategic approach to product offerings and market expansion, AXM Pharma, Inc. is well-positioned to capitalize on emerging opportunities in the pharmaceutical landscape.
AI Generated • Jul 14, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Las Vegas, NV 89103, US

AXMP Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

408.60M

Volume

300

Avg. Volume

10.32K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Axm Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$400.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IBXGiBX Group, Inc.
$0.00+0.00%
ROTHPharmaRoth Labs, Inc.
$0.00+0.00%
ONBIONE Bio Corp.
$0.00+0.00%
OMRXOrthometrix, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About AXMP

What is the current price of Axm Pharma?

Axm Pharma is trading at $0.00 per share.

What is the 52-week range for Axm Pharma?

Over the past 52 weeks, Axm Pharma has traded between $0.00 and $0.00.

How much debt does Axm Pharma have?

Axm Pharma total debt is unavailable.

How much cash does Axm Pharma have on hand?

Axm Pharma does not have cash on hand data available.

What is Axm Pharma’s dividend yield?

Axm Pharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services